May 14, 2026The Promising and Strange Future of Virtual Clinical TrialsThe Promising and Strange Future of Virtual Clinical Trials
May 7, 2026Cracking the Innovation Code: A Q&A with Vertex executive chairman Jeff LeidenCracking the Innovation Code: A Q&A with Vertex executive chairman Jeff Leiden
April 22, 2026Once More, With Feeling: AI Is Not Going to Replace Pharma Field ForcesOnce More, With Feeling: AI Is Not Going to Replace Pharma Field Forces
April 9, 2026The Kinara Innovation Playbook: Geetha Parachuru and Gilead’s Culture of Constructive DiscomfortThe Kinara Innovation Playbook: Geetha Parachuru and Gilead’s Culture of Constructive Discomfort
March 26, 2026Durable Innovation: A Q&A with Incoming Argenx CEO Karen MasseyDurable Innovation: A Q&A with Incoming Argenx CEO Karen Massey
March 17, 2026The Understated Evolution of the Medical Affairs FunctionThe Understated Evolution of the Medical Affairs Function
March 5, 2026Zero-Click Engagement: Designing for Invisible Influence in PharmaZero-Click Engagement: Designing for Invisible Influence in Pharma
February 25, 2026The Kinara Innovation Playbook: Phathom Pharmaceuticals and the Imperative to Swim Outside Your LaneThe Kinara Innovation Playbook: Phathom Pharmaceuticals and the Imperative to Swim Outside Your Lane
February 17, 2026The Kinara Innovation Playbook: AstraZeneca and the Discipline of Commercial InnovationThe Kinara Innovation Playbook: AstraZeneca and the Discipline of Commercial Innovation
